BioCentury
ARTICLE | Company News

Salix balsalazide approvable letter

March 27, 2000 8:00 AM UTC

Salix (TSE:SLX) received an approvable letter from the FDA for its balsalazide disodium to treat mild-to-moderate ulcerative colitis. The product is marketed in the U.K. to treat acute ulcerative coli...